Phase I study evaluating the safety, tolerability and maximally tolerated dose of L-000021649 administered in multiple doses

Trial Profile

Phase I study evaluating the safety, tolerability and maximally tolerated dose of L-000021649 administered in multiple doses

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 27 Jan 2006

At a glance

  • Drugs L 21649 (Primary)
  • Indications Acute myeloid leukaemia; Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 27 Jan 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top